Aerospace and Defense

Cadre

Cadre released FY2026 Q1 earnings on May 11 After-Market EST, actual revenue USD 155.43 M (forecast USD 155.32 M), actual EPS USD 0.0464 (forecast USD 0.072)

Cadre Holdings Inc reports Q1 2023 financials

Cadre to Release FY2026 Q1 Earnings on May 11 After-Market EST, Forecast Revenue USD 156.67 M, EPS USD 0.086

Cadre released FY2025 Q4 earnings on March 10 After-Market EST, actual revenue USD 167.22 M (forecast USD 182.94 M), actual EPS USD 0.2348 (forecast USD 0.4)

Cadre released FY2025 Annual Earnings on March 10 After-Market (EST), actual revenue USD 610.31 M (forecast USD 626.03 M), actual EPS USD 1.0199 (forecast USD 1.192)

Cadre to Release FY2025 Q4 Earnings on March 10 After-Market EST, Forecast Revenue USD 182.94 M, EPS USD 0.4

Cadre Holdings Inc.'s CFO Reports Disposal of Common Stock

Cadre Holdings CEO Sells Shares, Strong Company Performance

Cadre released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 155.87 M (forecast USD 158.96 M), actual EPS USD 0.269 (forecast USD 0.2614)

Cadre released FY2025 9 Months Earnings on November 4 After-Market EST, with actual revenue of USD 443.08 M and EPS of USD 0.7967

Cadre Holdings to Acquire TYR Tactical and Affiliates for $145 Million

Cadre Holdings Announces $175 Million Acquisition of TYR Tactical

Cadre to Release FY2025 Q3 Earnings on November 4 After-Market (EST), Forecast Revenue USD 158.96 M, EPS USD 0.2614

Cadre Holdings to release Q3 2025 financial results

Cadre Holdings Inc. CEO Disposes of Common Shares

Cadre Holdings Inc. President Disposes of Company Shares

Cadre released FY2025 Semi-Annual earnings on August 5 After-Market EST, actual revenue USD 287.22 M, actual EPS USD 0.52

Cadre released FY2025 Q2 earnings on August 5 After-Market EST, actual revenue USD 157.11 M (forecast USD 153.23 M), actual EPS USD 0.3 (forecast USD 0.2642)

Cadre to release FY2025 Q2 earnings report on August 5 After-Market EST, forecast revenue USD 153.23 M, EPS USD 0.2642

Warren B. Kanders Sells Cadre Holdings Inc. Common Stock

Co-Diagnostics

NewGenIvf

Agape ATP

Liminatus Pharma

Netcapital

Tradr 2X Long QBTS Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Tradr 2X Long RGTI Daily ETF

Sunshine Biopharma

Wheeler Real Estate

CDRE

Mark Smith from Lake Street has maintained a Buy rating on Cadre Holdings (CDRE) with a price target of $53.00. He is a 4-star analyst with a 6.7% average return and a 44.29% success rate, focusing on the Consumer Cyclical sector. The overall analyst consensus for Cadre Holdings is a Moderate Buy, with an average price target of $46.50.

Tip Ranks

Clarus

Lakeland Industries

Red Robin Gourmet

Lake Street Remains a Buy on Cadre Holdings (CDRE)

Cadre Hldgs (NYSE:CDRE) reported a 19% year-over-year increase in net sales for Q1 2026, driven by strong demand in law enforcement and military sectors. The company's orders backlog reached a record $355 million, indicating robust future demand. Cadre reaffirmed its 2026 guidance, expecting over 20% growth in net sales and adjusted EBITDA, supported by strategic acquisitions, including Pure Tactical for $175 million and Alien Gear Holsters for $10 million. Management emphasized resilience in their business model and ongoing focus on M&A and organic growth opportunities.

benzinga_article

ISHRS Aero & Def

Invesco Aero & Defense ETF

SPDR S&P Aerospace & Def

Cadre Hldgs Q1 2026 Earnings Call: Complete Transcript

Cadre (CDRE) reported Q1 earnings of $0.05 per diluted share, a decrease from $0.23 a year earlier, while revenue rose to $155.4 million from $130.1 million. Analysts had expected earnings of $0.07 and revenue of $155.3 million. For the full year 2026, Cadre anticipates net sales between $736 million and $758 million, with analysts expecting $740.3 million.

Fidelity

Factset Research

Cadre Q1 Earnings Fall, Revenue Rises

Earnings Watch

Cadre | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 155.43 M

AXON

BYRN

AXUP

Cadre (CDRE) is set to report its Q1 earnings, with expectations of a 19.1% revenue growth year-on-year, following a 5% decline last quarter. Analysts have maintained their estimates, despite Cadre's history of missing revenue targets. In comparison, peers Axon and Byrna reported revenue growths of 33.7% and 10.9%, respectively. Cadre's stock has decreased by 7.7% recently, with an average analyst price target of $48.80 against its current price of $30.15. Investors are keenly watching the earnings report for insights into the company's performance.

Stock Story

Axon Enterprise

Byrna Tech

T-REX 2X Long AXON Daily Target ETF

Cadre (CDRE) Q1 Earnings Report Preview: What To Look For

Cadre Holdings, Inc. (NYSE:CDRE) will trade ex-dividend in 3 days, with a dividend of US$0.10 per share payable on May 15. Investors buying shares on or after May 1 will not receive this dividend. The company has a trailing yield of 1.4% based on a share price of US$29.46, and it pays out 35% of its earnings and 27% of its free cash flow in dividends, indicating sustainability. However, earnings per share have declined by 5.9% annually over the past five years, raising concerns about future dividend stability. Overall, while the stock is not seen as a strong buy for dividends, it may still be worth considering with caution.

Simplywall

Is It Worth Considering Cadre Holdings, Inc. (NYSE:CDRE) For Its Upcoming Dividend?

DGICA

EARN

CALM

This week, ten dividend stocks are nearing their ex-dividend dates and are trading close to their 52-week lows. Investors must purchase these stocks before the ex-dividend dates to qualify for the upcoming payouts. The stocks include VALU, CALM, CAG, EARN, ORC, AOS, SMA, ADC, CDRE, and DGICA. TipRanks offers a Dividend Calendar for details on current and upcoming dividends and payment dates, along with a 30% discount on investment tools for smarter decisions.

Cadre(CDRE.US)